Patents Assigned to Novartis Animal Health US Inc.
  • Patent number: 7501128
    Abstract: A vaccine comprises a portion of IHNV G protein and a portion of a second protein from a fish pathogen, or their respective nucleic acid coding sequences. The presence of the IHNV G protein boosts the immune response to the second protein, resulting in a protective effect against infection by the fish pathogen and/or mortality caused by the fish pathogen from which the second protein is derived.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: March 10, 2009
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Nathalie C Simard, Linda M Bootland
  • Patent number: 7485751
    Abstract: The invention is directed at a new process for the preparation of pure enantiomers from the racemate of amidoacetonitrile compounds of formula wherein R1, R2 and R3, independently of each other, signify hydrogen, halogen, nitro, cyano, C1-C6-alkyl, halogen-C1-C6-alkyl, C1-C6-alkoxy, halogen-C1-C6-alkoxy, C2-C6-alkenyl, halogen-C2-C6-alkenyl, C2-C6-alkinyl, halogen-C2-C6-alkinyl, C2-C6-alkenyloxy, halogen-C2-C6-alkenyloxy, C1-C6-alkylthio, halogen-C1-C6-alkylthio, C1-C6-alkylsulfonyloxy, halogen-C1-C6-alkylsulfonyloxy, C1-C6-alkylsulfinyl, halogen-C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, halogen-C1-C6-alkylsulfonyl, C1-C6-alkenylthio, halogen-C1-C6-alkenylthio, C1-C6-alkenylsulfinyl, halogen-C1-C6-alkenylsulfinyl, C1-C6-alkenylsulfonyl, halogen-C1-C6-alkenylsulfonyl, C1-C6-alkylamino, di-(C1-C6-alkyl)amino, C1-C6-alkylaminocarbonyl, di-(C1-C6-alkyl)aminocarbonyl, C1-C6-alkylsulfonylamino, halogen-C1-C6-alkylsulfonylamino, C1-C6-alkylcarbonyl, halogen-C1-C6-alkylcarbonyl, C1-C6-alkoxycarbonyl, unsubstitut
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: February 3, 2009
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Noelle Gauvry, Thomas Goebel, Francois Pautrat
  • Patent number: 7446219
    Abstract: The invention relates to compounds of the general formula in which R1, R2, R3, R4, R5, R6, W, X, A1, A2, a, b and c are as defined in the specification, and to any enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are particularly suitable for controlling parasites in warm-blooded animals.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: November 4, 2008
    Assignee: Novartis Animal Health US Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jacques Bouvier, Corinne Durano
  • Patent number: 7304018
    Abstract: The invention relates to compounds of the general formula: (I) and optionally the enantiomers thereof. The active ingredients have advantages pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
    Type: Grant
    Filed: June 15, 2003
    Date of Patent: December 4, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jacques Bouvier
  • Patent number: 7297783
    Abstract: The hsp60 gene from a strain of Arthrobacter has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: November 20, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Steven G Griffiths, Rachael J Ritchie, Nathalie C Simard
  • Patent number: 7279495
    Abstract: The invention relates to compounds of the general formula wherein R1, R2, R3, R4, R5, R6, R7, X, Y and a have the significances given in the patent, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: October 9, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel
  • Patent number: 7271184
    Abstract: Novel pesticides of formula (I) wherein the substituents, R, R1, R2, R2?, T, U, X and Y are as defined in claim 1, are described. Also described are compositions suitable for use as parasiticides comprising those compounds as active ingredient and to methods of controlling parasites that are based on the administration of those compounds or compositions, and to the use of the said compounds and compositions in a method of controlling parasites and in the manufacture of pesticides for use against parasites. Also described are intermediates of formula (XX) wherein R1, R2, R2?, T, U, X and Y are as defined in claim 1; and Hal is halogen. The latter also exhibit parasiticidal activity and are suitable for the preparation of the compounds of formula (I).
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: September 18, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Thomas Goebel, Eliane Humbert-Droz, Maurizio Schwarzenbach
  • Patent number: 7262209
    Abstract: The invention relates to compounds of the general formula wherein Ar1, Ar2, R4, R5, R6, R7, R8, W, X, a and b have the significances given in the specification, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: August 28, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Thomas Goebel, Pierre Ducray
  • Patent number: 7250436
    Abstract: The invention relates to compounds of the general formula wherein Ar1, Ar2, R4, R5, R6, R7, R8, W, X, a and b have the significances given in the specification, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: July 31, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jorg Fruchtel
  • Patent number: 7153814
    Abstract: The invention relates to compounds of the general formula (I), in which Ar, R1, R2, R3, R4, R5, R6, R7, R8, W, a, b and n are as defined in claim 1, and to any enantiomers thereof. The active ingredients have advantageous pesticidal properties.
    Type: Grant
    Filed: January 20, 2003
    Date of Patent: December 26, 2006
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jorg Fruchtel, Jacques Bouvier
  • Patent number: 7148255
    Abstract: The invention relates to compounds of formula I wherein R1, R2, R3, R4, R5, R6, R8, R8?, R9, W, X, A1, A2, a, b and c have the significances given in the specification, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: December 12, 2006
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jacques Bouvier, Corinne Durano
  • Patent number: 7091371
    Abstract: The invention relates to compounds of the general formula (I), in which R1, R2, X, Ar1 and Ar2 are as defined in claim 1, and to any enantiomers thereof. The active ingredients have advantageous pesticidal properties.
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: August 15, 2006
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel
  • Patent number: 7063856
    Abstract: The invention relates to a composition for controlling a pest, including endoparasites, and more specifically helminths, of formula (I) in animals, and methods related to thereof.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: June 20, 2006
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Jacques Bouvier
  • Patent number: 7052707
    Abstract: The invention relates to a composition for controlling a pest, including endoparasites, and more specifically helminths, of formula (I) in animals, and methods related to thereof.
    Type: Grant
    Filed: January 21, 2002
    Date of Patent: May 30, 2006
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Jacques Bouvier
  • Patent number: 6982285
    Abstract: A method of successfully controlling sea lice in commercial fish farming, in an efficient and environmentally friendly way, with the compounds named in claim 1, preferably by injection, and a method of automating this type of control, are described.
    Type: Grant
    Filed: January 22, 2003
    Date of Patent: January 3, 2006
    Assignee: Novartis Animal Health US, Inc.
    Inventor: Hariolf Schmid
  • Patent number: 6852756
    Abstract: Described is a method for transdermally controlling a bacterial infection in a non-human animal which comprises the step of topically applying to the non-human animal a medicament comprising valnemulin in free base or a pharmaceutically acceptable salt form.
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: February 8, 2005
    Assignee: Novartis Animal Health US Inc.
    Inventors: Paul Howard Ripley, Erich Zeisl, Stefan Horkovics-Kovats
  • Patent number: 6780876
    Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known compounds of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defence against vermin. Thus, the invention describes how and in which form the compounds of formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: August 24, 2004
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Olivier Froelich, Jacques Bouvier, Catherine Christinaz, Nicola Di Criscio
  • Patent number: 6759407
    Abstract: Novel pesticides of formula (I) wherein the substituents, R, R1, R2, R2′, T, U, X and Y are as defined in claim 1, are described. Also described are compositions suitable for use as parasiticides comprising those compounds as active ingredient and to methods of controlling parasites that are based on the administration of those compounds or compositions, and to the use of the said compounds and compositions in a method of controlling parasites and in the manufacture of pesticides for use against parasites. Also described are intermediates of formula (XX) wherein R1, R2, R2′, T, U, X and Y are as defined in claim 1; and Hal is halogen. The latter also exhibit parasiticidal activity and are suitable for the preparation of the compounds of formula (I).
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: July 6, 2004
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Thomas Goebel, Eliane Humbert-Droz, Maurizio Schwarzenbach
  • Patent number: 6723720
    Abstract: A compound of formula wherein R1 is unsubstituted or substituted aryl or heteroaryl, the substituents of the aryl and heteroaryl rings being selected, for example, from the group consisting of OH, halogen, CN, NO2, C1-C6alkyl, C3-C8cycloalkyl, C1-C6alkyl-C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C6alkyl, C1-C6haloalkyl, C3-C8halocycloalkyl, C1-C6alkoxy and phenyl; phenoxy; phenylthio; phenylamino; and phenyl-(C1-C6alkyl)-amino; the substituents of the phenoxy, phenylthio, phenylamino and phenyl-(C1-C6alkyl)-amino groups being selected from the group consisting of halogen, CN, NO2, C1-C6alkyl, C3-C8cycloalkyl, C1-C6haloalkyl, C3-C8halocycloalkyl, C1-C6alkoxy, C3-C8cycloalkoxy, C1-C6alkylthio, C3-C8cycloalkylthio, C1-C6haloalkylthio and C3-C8halocycloalkylthio; R2 is, for example, H, OH, halogen, CN, NO2, C1-C6alkyl or C1-C6alkoxy; A is, for example, a single bond, C1-C12alkylene, O or O(C1-C12alkylene); R4 is H, C1-C6alkyl, C3-C8cycloalkyl, C1-C6haloalkyl, C1-C6alkoxy, N(R5)2 or C1-C6alkoxy-C
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: April 20, 2004
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Arthur Steiger, Werner Zambach, André Jeanguenat, Martin Eberle, Stephan Trah, Saleem Farooq
  • Patent number: 6686469
    Abstract: The invention relates to compounds of the general formula wherein R1 is unsubstituted or mono- to penta-substituted aryl, whereby the substituents are selected from the group consisting for instance of OH, Halogen, CN, C1-C6-alkyl, optionally substituted C3-C8-cycloalkyl and optionally substituted C3-C8-cycloalkenyl; A is for instance a single bond, C1-C12-alkylene or O; X1 and X2, independently of one another, are R10; X3 is H or R10; R10 is for instance halogen, CN, NO2, C1-C6-alkyl, C3-C8-cycloalkyl or C1-C6-haloalkyl; R21 and R22, independently of one another are for instance H, halogen, CN, NO2, OH, SH, C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-alkyl-C3-C8-cycloalkyl or C3-C8-cycloalkyl-C1-C6-alkyl; R23 and R24, independently of one another, are for instance H, C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C6-alkyl, C1-C6-haloalkyl or C3-C8-halocycloalkyl; m is 1, 2, 3 or 4; and n is 0, 1 or 2; as well as the physiologically acceptable addition compounds, a method of producing
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: February 3, 2004
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Martin Eberle, André Jeanguenat, Werner Zambach, Arthur Steiger, Saleem Farooq